EP2246067 - Methods to elicit, enhance and sustain immune responses against MHC class I-restricted epitopes, for prophylactic or therapeutic purposes [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 22.12.2017 Database last updated on 31.08.2024 | |
Former | The patent has been granted Status updated on 13.01.2017 | Most recent event Tooltip | 06.03.2020 | Lapse of the patent in a contracting state New state(s): TR | published on 08.04.2020 [2020/15] | Applicant(s) | For all designated states MannKind Corporation 25134 Rye Canyon Loop, Suite 300 Valencia, CA 91355 / US | [2017/07] |
Former [2015/51] | For all designated states MannKind Corporation 25134 Rye Canyon Loop Valencia CA 91355 / US | ||
Former [2010/44] | For all designated states Mannkind Corporation 28903 North Avenue Paine Valencia California 91355 / US | Inventor(s) | 01 /
Bot, Adrian Ion 24406 West Gable Ranch Lane Valencia, CA 91354 / US | 02 /
Liu, Xiping 6035 Camellia Avenue Temple City, CA 91780 / US | 03 /
Smith, Kent, Andrew 2916 Bayshore Avenue Ventura, CA 93001 / US | [2017/07] |
Former [2011/08] | 01 /
Bot, Adrian Ion 24406 West Gable Ranch Lane Valencia, CA 91354 / US | ||
02 /
Liu, Xiping 6035 Camellia Avenue Temple City, CA 91780 / US | |||
03 /
Smith, Kent, Andrew 2916 Bayshore Avenue Ventura, CA 93001 / US | |||
Former [2010/44] | 01 /
Bot, Adrian, Ion 27003 Carmelita Drive Valencia, CA 91355 / US | ||
02 /
Liu, Xiping 6035 Camellia Avenue Temple City, CA 91780 / US | |||
03 /
Smith, Kent, Andrew 2916 Bayshore Avenue Ventura, CA 93001 / US | Representative(s) | Neuefeind, Regina Maiwald GmbH Elisenhof Elisenstraße 3 80335 München / DE | [N/P] |
Former [2017/07] | Neuefeind, Regina Maiwald Patentanwalts GmbH Elisenhof Elisenstrasse 3 80335 München / DE | ||
Former [2010/44] | Neuefeind, Regina Maiwald Patentanwalts GmbH Elisenhof Elisenstrasse 3 80335 München / DE | Application number, filing date | 10171754.4 | 17.06.2004 | [2010/44] | Priority number, date | US20030479393P | 17.06.2003 Original published format: US 479393 P | [2010/44] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | EP2246067 | Date: | 03.11.2010 | Language: | EN | [2010/44] | Type: | A3 Search report | No.: | EP2246067 | Date: | 13.07.2011 | [2011/28] | Type: | B1 Patent specification | No.: | EP2246067 | Date: | 15.02.2017 | Language: | EN | [2017/07] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 15.06.2011 | Classification | IPC: | A61K39/00, A61P35/00, A61P37/00 | [2010/44] | CPC: |
A61K39/00 (EP,US);
A61K39/0011 (EP,US);
A61P25/00 (EP);
A61P31/04 (EP);
A61P31/10 (EP);
A61P31/12 (EP);
A61P33/02 (EP);
A61P35/00 (EP);
A61P37/00 (EP);
A61K2039/5154 (EP,US);
A61K2039/5156 (EP,US);
A61K2039/53 (EP,US);
| Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IT, LI, LU, MC, NL, PL, PT, RO, SE, SI, SK, TR [2017/07] |
Former [2010/44] | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IT, LI, LU, MC, NL, PL, PT, RO, SE, SI, SK, TR | Title | German: | Verfahren zur Auslösung, Verstärkung und Aufrechterhaltung von Immunreaktionen gegen eingeschränkte Klasse-I-MHC-epitope für prophylaktische oder therapeutische Zwecke | [2010/44] | English: | Methods to elicit, enhance and sustain immune responses against MHC class I-restricted epitopes, for prophylactic or therapeutic purposes | [2010/44] | French: | Procédés destinés à susciter, améliorer et entretenir les réponses immunitaires contre des épitopes limités au CMH de classe I dans des buts prophylactiques ou thérapeutiques | [2016/26] |
Former [2010/44] | Procédés destinés à susciter, améliorer et entretenir les réponses immunitaires contre des épitopes limités au CMH de classe I dans des buts prophylactiques ou thérapeutiques | Examination procedure | 13.01.2012 | Amendment by applicant (claims and/or description) | 13.01.2012 | Examination requested [2012/08] | 26.09.2013 | Despatch of a communication from the examining division (Time limit: M04) | 06.02.2014 | Reply to a communication from the examining division | 30.09.2014 | Despatch of a communication from the examining division (Time limit: M01) | 30.10.2014 | Reply to a communication from the examining division | 13.07.2015 | Communication of intention to grant the patent | 23.11.2015 | Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO | 23.11.2015 | Fee for grant paid | 23.11.2015 | Fee for publishing/printing paid | 08.12.2015 | Despatch of a communication from the examining division (Time limit: M02) | 15.02.2016 | Reply to a communication from the examining division | 08.06.2016 | Communication of intention to grant the patent | 16.06.2016 | Fee for grant paid | 16.06.2016 | Fee for publishing/printing paid | 16.06.2016 | Receipt of the translation of the claim(s) | Parent application(s) Tooltip | EP04776760.3 / EP1635863 | Divisional application(s) | EP10180566.1 / EP2356999 | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued (EP20040776760) is 03.04.2007 | Opposition(s) | 16.11.2017 | No opposition filed within time limit [2018/04] | Fees paid | Renewal fee | 03.08.2010 | Renewal fee patent year 03 | 03.08.2010 | Renewal fee patent year 04 | 03.08.2010 | Renewal fee patent year 05 | 03.08.2010 | Renewal fee patent year 06 | 03.08.2010 | Renewal fee patent year 07 | 27.06.2011 | Renewal fee patent year 08 | 31.03.2012 | Renewal fee patent year 09 | 27.06.2013 | Renewal fee patent year 10 | 30.06.2014 | Renewal fee patent year 11 | 29.06.2015 | Renewal fee patent year 12 | 29.12.2016 | Renewal fee patent year 13 | Penalty fee | Additional fee for renewal fee | 30.06.2016 | 13   M06   Fee paid on   29.12.2016 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Lapses during opposition Tooltip | HU | 17.06.2004 | AT | 15.02.2017 | CY | 15.02.2017 | CZ | 15.02.2017 | DK | 15.02.2017 | EE | 15.02.2017 | ES | 15.02.2017 | FI | 15.02.2017 | IT | 15.02.2017 | MC | 15.02.2017 | NL | 15.02.2017 | PL | 15.02.2017 | RO | 15.02.2017 | SE | 15.02.2017 | SI | 15.02.2017 | SK | 15.02.2017 | TR | 15.02.2017 | BG | 15.05.2017 | GR | 16.05.2017 | PT | 15.06.2017 | GB | 17.06.2017 | IE | 17.06.2017 | LU | 17.06.2017 | BE | 30.06.2017 | CH | 30.06.2017 | FR | 30.06.2017 | LI | 30.06.2017 | [2020/15] |
Former [2019/46] | HU | 17.06.2004 | |
AT | 15.02.2017 | ||
CY | 15.02.2017 | ||
CZ | 15.02.2017 | ||
DK | 15.02.2017 | ||
EE | 15.02.2017 | ||
ES | 15.02.2017 | ||
FI | 15.02.2017 | ||
IT | 15.02.2017 | ||
MC | 15.02.2017 | ||
NL | 15.02.2017 | ||
PL | 15.02.2017 | ||
RO | 15.02.2017 | ||
SE | 15.02.2017 | ||
SI | 15.02.2017 | ||
SK | 15.02.2017 | ||
BG | 15.05.2017 | ||
GR | 16.05.2017 | ||
PT | 15.06.2017 | ||
GB | 17.06.2017 | ||
IE | 17.06.2017 | ||
LU | 17.06.2017 | ||
BE | 30.06.2017 | ||
CH | 30.06.2017 | ||
FR | 30.06.2017 | ||
LI | 30.06.2017 | ||
Former [2019/31] | HU | 17.06.2004 | |
AT | 15.02.2017 | ||
CZ | 15.02.2017 | ||
DK | 15.02.2017 | ||
EE | 15.02.2017 | ||
ES | 15.02.2017 | ||
FI | 15.02.2017 | ||
IT | 15.02.2017 | ||
MC | 15.02.2017 | ||
NL | 15.02.2017 | ||
PL | 15.02.2017 | ||
RO | 15.02.2017 | ||
SE | 15.02.2017 | ||
SI | 15.02.2017 | ||
SK | 15.02.2017 | ||
BG | 15.05.2017 | ||
GR | 16.05.2017 | ||
PT | 15.06.2017 | ||
GB | 17.06.2017 | ||
IE | 17.06.2017 | ||
LU | 17.06.2017 | ||
BE | 30.06.2017 | ||
CH | 30.06.2017 | ||
FR | 30.06.2017 | ||
LI | 30.06.2017 | ||
Former [2018/39] | AT | 15.02.2017 | |
CZ | 15.02.2017 | ||
DK | 15.02.2017 | ||
EE | 15.02.2017 | ||
ES | 15.02.2017 | ||
FI | 15.02.2017 | ||
IT | 15.02.2017 | ||
MC | 15.02.2017 | ||
NL | 15.02.2017 | ||
PL | 15.02.2017 | ||
RO | 15.02.2017 | ||
SE | 15.02.2017 | ||
SI | 15.02.2017 | ||
SK | 15.02.2017 | ||
BG | 15.05.2017 | ||
GR | 16.05.2017 | ||
PT | 15.06.2017 | ||
GB | 17.06.2017 | ||
IE | 17.06.2017 | ||
LU | 17.06.2017 | ||
BE | 30.06.2017 | ||
CH | 30.06.2017 | ||
FR | 30.06.2017 | ||
LI | 30.06.2017 | ||
Former [2018/29] | AT | 15.02.2017 | |
CZ | 15.02.2017 | ||
DK | 15.02.2017 | ||
EE | 15.02.2017 | ||
ES | 15.02.2017 | ||
FI | 15.02.2017 | ||
IT | 15.02.2017 | ||
MC | 15.02.2017 | ||
NL | 15.02.2017 | ||
PL | 15.02.2017 | ||
RO | 15.02.2017 | ||
SE | 15.02.2017 | ||
SI | 15.02.2017 | ||
SK | 15.02.2017 | ||
BG | 15.05.2017 | ||
GR | 16.05.2017 | ||
PT | 15.06.2017 | ||
GB | 17.06.2017 | ||
IE | 17.06.2017 | ||
LU | 17.06.2017 | ||
CH | 30.06.2017 | ||
FR | 30.06.2017 | ||
LI | 30.06.2017 | ||
Former [2018/23] | AT | 15.02.2017 | |
CZ | 15.02.2017 | ||
DK | 15.02.2017 | ||
EE | 15.02.2017 | ||
ES | 15.02.2017 | ||
FI | 15.02.2017 | ||
IT | 15.02.2017 | ||
MC | 15.02.2017 | ||
NL | 15.02.2017 | ||
PL | 15.02.2017 | ||
RO | 15.02.2017 | ||
SE | 15.02.2017 | ||
SI | 15.02.2017 | ||
SK | 15.02.2017 | ||
BG | 15.05.2017 | ||
GR | 16.05.2017 | ||
PT | 15.06.2017 | ||
GB | 17.06.2017 | ||
IE | 17.06.2017 | ||
LU | 17.06.2017 | ||
CH | 30.06.2017 | ||
LI | 30.06.2017 | ||
Former [2018/21] | AT | 15.02.2017 | |
CZ | 15.02.2017 | ||
DK | 15.02.2017 | ||
EE | 15.02.2017 | ||
ES | 15.02.2017 | ||
FI | 15.02.2017 | ||
IT | 15.02.2017 | ||
MC | 15.02.2017 | ||
NL | 15.02.2017 | ||
PL | 15.02.2017 | ||
RO | 15.02.2017 | ||
SE | 15.02.2017 | ||
SI | 15.02.2017 | ||
SK | 15.02.2017 | ||
BG | 15.05.2017 | ||
GR | 16.05.2017 | ||
PT | 15.06.2017 | ||
GB | 17.06.2017 | ||
LU | 17.06.2017 | ||
CH | 30.06.2017 | ||
LI | 30.06.2017 | ||
Former [2018/14] | AT | 15.02.2017 | |
CZ | 15.02.2017 | ||
DK | 15.02.2017 | ||
EE | 15.02.2017 | ||
ES | 15.02.2017 | ||
FI | 15.02.2017 | ||
IT | 15.02.2017 | ||
MC | 15.02.2017 | ||
NL | 15.02.2017 | ||
PL | 15.02.2017 | ||
RO | 15.02.2017 | ||
SE | 15.02.2017 | ||
SI | 15.02.2017 | ||
SK | 15.02.2017 | ||
BG | 15.05.2017 | ||
GR | 16.05.2017 | ||
PT | 15.06.2017 | ||
Former [2018/11] | AT | 15.02.2017 | |
CZ | 15.02.2017 | ||
DK | 15.02.2017 | ||
EE | 15.02.2017 | ||
ES | 15.02.2017 | ||
FI | 15.02.2017 | ||
IT | 15.02.2017 | ||
MC | 15.02.2017 | ||
NL | 15.02.2017 | ||
PL | 15.02.2017 | ||
RO | 15.02.2017 | ||
SE | 15.02.2017 | ||
SK | 15.02.2017 | ||
BG | 15.05.2017 | ||
GR | 16.05.2017 | ||
PT | 15.06.2017 | ||
Former [2017/50] | AT | 15.02.2017 | |
CZ | 15.02.2017 | ||
DK | 15.02.2017 | ||
EE | 15.02.2017 | ||
ES | 15.02.2017 | ||
FI | 15.02.2017 | ||
IT | 15.02.2017 | ||
NL | 15.02.2017 | ||
PL | 15.02.2017 | ||
RO | 15.02.2017 | ||
SE | 15.02.2017 | ||
SK | 15.02.2017 | ||
BG | 15.05.2017 | ||
GR | 16.05.2017 | ||
PT | 15.06.2017 | ||
Former [2017/49] | AT | 15.02.2017 | |
CZ | 15.02.2017 | ||
EE | 15.02.2017 | ||
ES | 15.02.2017 | ||
FI | 15.02.2017 | ||
IT | 15.02.2017 | ||
NL | 15.02.2017 | ||
RO | 15.02.2017 | ||
SE | 15.02.2017 | ||
SK | 15.02.2017 | ||
BG | 15.05.2017 | ||
GR | 16.05.2017 | ||
PT | 15.06.2017 | ||
Former [2017/48] | AT | 15.02.2017 | |
CZ | 15.02.2017 | ||
ES | 15.02.2017 | ||
FI | 15.02.2017 | ||
NL | 15.02.2017 | ||
SE | 15.02.2017 | ||
BG | 15.05.2017 | ||
GR | 16.05.2017 | ||
PT | 15.06.2017 | ||
Former [2017/42] | AT | 15.02.2017 | |
ES | 15.02.2017 | ||
FI | 15.02.2017 | ||
NL | 15.02.2017 | ||
SE | 15.02.2017 | ||
BG | 15.05.2017 | ||
GR | 16.05.2017 | ||
PT | 15.06.2017 | Documents cited: | Search | [Y]WO9858956 (LUDWIG INST CANCER RES [US]); | [XYI]WO0130382 (AVENTIS PASTEUR [CA], et al); | [A]WO0228429 (ALLECURE CORP [US], et al); | [A]WO03011331 (ISIS INNOVATION [GB], et al); | Examination | WO02080648 | by applicant | WO9902183 | US2002007173 | US2003026231 | US2003046714 | US2003138808 | US2003215425 | US2003220239 | US2003228634 | WO2004018666 | WO2004022709 | US6709844 | WO1998US14289 | US19990380534 | US20000561571 | US20000560465 | US20000561074 | US20000561572 | US20010776232 | US20010282211 | US20010337017 | US20010026066 | US20020363210 | US20020094699 | US20020117937 | US20020409123 | US20020255568 | US20020292413 | US20030479393 | US20030479554 | US20030657022 | WO2003US27706 |